CYP1A2 c.895G>A ;(p.G299S)

Variant ID: 15-75043593-G-A

NM_000761.3(CYP1A2):c.895G>A;(p.G299S)

This variant was identified in 12 publications

View GRCh38 version.




Publications:


Correlation of changes in subclonal architecture with progression in the MMRF CoMMpass study.

Translational Oncology
Kaur, Gurvinder G; Jena, Lingaraja L; Gupta, Ritu R; Farswan, Akanksha A; Gupta, Anubha A; Sriram, K K
Publication Date: 2022-06-28

Variant appearance in text: CYP1A2: 895G>A; Gly299Ser
PubMed Link: 35777247
Variant Present in the following documents:
  • mmc5.xls, sheet 3
View BVdb publication page



"Commandeuring" Xenobiotic Metabolism: Advances in Understanding Xenobiotic Metabolism.

Chemical Research In Toxicology
van Vugt-Lussenburg, Barbara M A BMA; Capinha, Liliana L; Reinen, Jelle J; Rooseboom, Martijn M; Kranendonk, Michel M; Onderwater, Rob C A RCA; Jennings, Paul P
Publication Date: 2022-07-18

Variant appearance in text: CYP1A2: G299S
PubMed Link: 35768066
Variant Present in the following documents:
  • Main text
  • tx2c00067.pdf
View BVdb publication page



Pharmacogenetics and Pain Treatment with a Focus on Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Antidepressants: A Systematic Review.

Pharmaceutics
Zobdeh, Farzin F; Eremenko, Ivan I II; Akan, Mikail A MA; Tarasov, Vadim V VV; Chubarev, Vladimir N VN; Schiöth, Helgi B HB; Mwinyi, Jessica J
Publication Date: 2022-06-01

Variant appearance in text: rs35796837
PubMed Link: 35745763
Variant Present in the following documents:
  • Main text
  • pharmaceutics-14-01190.pdf
View BVdb publication page



In silico screening and analysis of nonsynonymous SNPs in human CYP1A2 to assess possible associations with pathogenicity and cancer susceptibility.

Scientific Reports
Navapour, Leila L; Mogharrab, Navid N
Publication Date: 2021-03-02

Variant appearance in text: CYP1A2: G299S; rs35796837
PubMed Link: 33654112
Variant Present in the following documents:
View BVdb publication page



An optimized prediction framework to assess the functional impact of pharmacogenetic variants.

The Pharmacogenomics Journal
Zhou, Yitian Y; Mkrtchian, Souren S; Kumondai, Masaki M; Hiratsuka, Masahiro M; Lauschke, Volker M VM
Publication Date: 2019-04

Variant appearance in text: CYP1A2: G299S; rs35796837
PubMed Link: 30206299
Variant Present in the following documents:
  • 41397_2018_44_MOESM5_ESM.xlsx, sheet 1
View BVdb publication page



Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease.

Neurology
Fujimaki, Motoki M; Saiki, Shinji S; Li, Yuanzhe Y; Kaga, Naoko N; Taka, Hikari H; Hatano, Taku T; Ishikawa, Kei-Ichi KI; Oji, Yutaka Y; Mori, Akio A; Okuzumi, Ayami A; Koinuma, Takahiro T; Ueno, Shin-Ichi SI; Imamichi, Yoko Y; Ueno, Takashi T; Miura, Yoshiki Y; Funayama, Manabu M; Hattori, Nobutaka N
Publication Date: 2018-01-30

Variant appearance in text: CYP1A2: 895G>A; Gly299Ser; rs35796837
PubMed Link: 29298852
Variant Present in the following documents:
  • Main text
  • NEUROLOGY2017821272.pdf
View BVdb publication page



Investigation of the major cytochrome P450 1A2 genetic variant in a healthy Tibetan population in China.

Molecular Medicine Reports
Ren, Yongchao Y; Liu, Fang F; Shi, Xugang X; Geng, Tingting T; Yuan, Dongya D; Wang, Li L; Kang, Longli L; Jin, Tianbo T; Chen, Chao C
Publication Date: 2017-07

Variant appearance in text: CYP1A2: Gly299Ser
PubMed Link: 28560456
Variant Present in the following documents:
  • Main text
  • mmr-16-01-0573.pdf
View BVdb publication page



Characterization of ADME gene variation in 21 populations by exome sequencing.

Pharmacogenetics And Genomics
Hovelson, Daniel H DH; Xue, Zhengyu Z; Zawistowski, Matthew M; Ehm, Margaret G MG; Harris, Elizabeth C EC; Stocker, Sophie L SL; Gross, Annette S AS; Jang, In-Jin IJ; Ieiri, Ichiro I; Lee, Jong-Eun JE; Cardon, Lon R LR; Chissoe, Stephanie L SL; Abecasis, Gonçalo G; Nelson, Matthew R MR
Publication Date: 2017-03

Variant appearance in text: rs35796837
PubMed Link: 27984508
Variant Present in the following documents:
  • fpc-27-089-s005.xlsx, sheet 2
View BVdb publication page



Reproducible Analysis of Post-Translational Modifications in Proteomes--Application to Human Mutations.

Plos One
Holehouse, Alex S AS; Naegle, Kristen M KM
Publication Date: 2015

Variant appearance in text: rs35796837
PubMed Link: 26659599
Variant Present in the following documents:
  • pone.0144692.s002.xlsx, sheet 1
View BVdb publication page



GESPA: classifying nsSNPs to predict disease association.

Bmc Bioinformatics
Khurana, Jay K JK; Reeder, Jay E JE; Shrimpton, Antony E AE; Thakar, Juilee J
Publication Date: 2015-07-25

Variant appearance in text: CYP1A2: G299S
PubMed Link: 26206375
Variant Present in the following documents:
  • 12859_2015_673_MOESM1_ESM.xls, sheet 5
View BVdb publication page



Differences in Methadone Metabolism by CYP2B6 Variants.

Drug Metabolism And Disposition: The Biological Fate Of Chemicals
Gadel, Sarah S; Friedel, Christina C; Kharasch, Evan D ED
Publication Date: 2015-07

Variant appearance in text: CYP1A2: Gly299Ser
PubMed Link: 25897175
Variant Present in the following documents:
  • Main text
View BVdb publication page



Increased genetic diversity of ADME genes in African Americans compared with their putative ancestral source populations and implications for pharmacogenomics.

Bmc Genetics
Li, Jing J; Lao, Xingzhen X; Zhang, Chao C; Tian, Lei L; Lu, Dongsheng D; Xu, Shuhua S
Publication Date: 2014-05-01

Variant appearance in text: rs35796837
PubMed Link: 24884825
Variant Present in the following documents:
  • Main text
  • 1471-2156-15-52.pdf
View BVdb publication page